This inventor holds 3 USPTO granted patents. Top assignee: Massachusetts Institute of Technology. Active years: 2018-2021.
Company Filing History:
Years Active: 2018-2021
Title: Innovations and Contributions of Nicholas B. Struntz
Introduction
Nicholas B. Struntz is a prominent inventor based in Cambridge, MA (US). He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target specific receptors involved in cancer treatment. With a total of 3 patents, his work has the potential to impact therapeutic strategies for various diseases.
Latest Patents
One of his latest patents is titled "Small molecule modulators of the androgen receptor." This patent provides compounds that are useful for modulating the activity of the androgen receptor and its variants. These compounds are particularly effective in antagonizing the androgen receptor splice variant AR-v7, which is crucial for the treatment of castration-resistant prostate cancer.
Another notable patent is "Max binders as MYC modulators and uses thereof." This disclosure presents compounds that act as MAX binders and modulators of Myc, Mad, or Mxi1. These compounds may be beneficial in treating diseases associated with Myc, such as various forms of cancer. The patent also includes pharmaceutical compositions and methods for utilizing these compounds effectively.
Career Highlights
Nicholas B. Struntz is affiliated with the Massachusetts Institute of Technology, where he conducts research and development in the field of drug discovery. His innovative work has garnered attention in the scientific community, contributing to advancements in cancer therapeutics.
Collaborations
He has collaborated with notable colleagues, including Angela N. Koehler and Francisco Caballero. These partnerships have fostered a collaborative environment that enhances the research output and innovation in their respective fields.
Conclusion
Nicholas B. Struntz's contributions to medicinal chemistry and his innovative patents highlight his role as a key figure in the fight against cancer. His work continues to pave the way for new therapeutic approaches that could significantly improve patient outcomes.